Login / Signup

Adding colchicine to tocilizumab in hospitalized patients with severe COVID-19 pneumonia: An open-label randomized controlled trial.

Alaa RahhalMostafa NajimAmer Hussein AljundiAhmed MahfouzSumaya Mehdar AlyafeiAhmed AwaisuMhd Baraa HabibIbrahim ObeidatMohanad Mohammed FaisalMeshaal Ali AlanziArun Prabhakaran NairAreeg ElhassanAbdullah Al-DushainAlaaeldin Abdelmajid AbdelmajidAhmed Elfadil AbdelgaderAhmed Mahmoud Ahmed MoursiAhmad Eid Nazzal AlharafshehMohd Ragheb Abou KamarWael GoraveyAmr Salah OmarMohammed AbukhattabMohamad Yahya KhatibMohamed Gaafar MohamedaliMuna A Rahman AlMaslamaniSamar Alemadi
Published in: Medicine (2022)
The Medical Research Center and Institutional Review Board at Hamad Medical Corporation in Qatar approved the study protocol (MRC-01-21-299). Results of the analysis will be submitted for publication in a peer-reviewed journal.
Keyphrases
  • randomized controlled trial
  • study protocol
  • healthcare
  • coronavirus disease
  • sars cov
  • rheumatoid arthritis
  • clinical trial
  • early onset
  • open label
  • juvenile idiopathic arthritis
  • respiratory failure